F J Gallego Rojo

Statistics

Publications

Citations

H-Index

Active since

2004

Affiliations

Bristol-Myers Squibb (United States)(Current)

F J Gallego Rojo is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, pharmacodynamics of anticancer drugs, and pharmacokinetics.

Publications per year

2004–2005

Publications

Phase I Pharmacokinetic and Pharmacodynamic Study of Weekly 1-Hour and 24-Hour Infusion BMS-214662, a Farnesyltransferase Inhibitor, in Patients With Advanced Solid Tumors

Josep Tabernero, F J Gallego Rojo, Irene Marimón et al. · Journal of Clinical Oncology · 2005 · 32 citations

Medicine, Pharmacokinetics, Pharmacology +13

A phase I/IIA pharmacokinetic (PK) and serial skin and tumor pharmacodynamic (PD) study of the EGFR irreversible tyrosine kinase inhibitor EKB-569 in combination with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) (FOLFIRI regimen) in patients (pts) with advanced colorectal cancer (ACC)

E. Casado, Gunnar Folprecht, L. Paz-Ares et al. · Journal of Clinical Oncology · 2004 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +17

1–2 of 2